An international multidisciplinary consensus statement on MAFLD and the risk of CVD.

ABSTRACT:

Background

Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25-30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has been proposed for this condition. MAFLD is closely intertwined with obesity, type 2 diabetes mellitus and atherogenic dyslipidemia, which are established cardiovascular risk factors. Unlike CVD, which has received attention in the literature on fatty liver disease, the CVD risk associated with MAFLD is often underestimated, especially among Cardiologists.

Methods and results

A multidisciplinary panel of fifty-two international exp

SUBMITTER: Zhou XD 

PROVIDER: S-EPMC10198034 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature